105 related articles for article (PubMed ID: 29334169)
1. Impact of baseline clinical and laboratory features on the risk of thrombosis in children with acute lymphoblastic leukemia: A prospective evaluation.
Athale UH; Mizrahi T; Laverdière C; Nayiager T; Delva YL; Foster G; Thabane L; David M; Leclerc JM; Chan AKC
Pediatr Blood Cancer; 2018 May; 65(5):e26938. PubMed ID: 29334169
[TBL] [Abstract][Full Text] [Related]
2. Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
Athale UH; Flamand Y; Blonquist T; Stevenson KE; Spira M; Asselin BL; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJG; Harris MH; Neuberg DS; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2022 Aug; 69(8):e29581. PubMed ID: 35316569
[TBL] [Abstract][Full Text] [Related]
3. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic events revisited in children with acute lymphoblastic leukemia: impact of concomitant Escherichia coli asparaginase/prednisone administration.
Nowak-Göttl U; Heinecke A; von Kries R; Nürnberger W; Münchow N; Junker R
Thromb Res; 2001 Aug; 103(3):165-72. PubMed ID: 11672578
[TBL] [Abstract][Full Text] [Related]
5. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand Factor and Factor VIII levels in Egyptian children with newly diagnosed acute lymphoblastic leukemia in relation to peripheral blast cells and steroid therapy.
El Sherif NH; Narouz MF; Elkerdany TA; El Habashy SA
J Pediatr Hematol Oncol; 2014 Oct; 36(7):518-23. PubMed ID: 25105915
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
Athale UH; Siciliano SA; Crowther M; Barr RD; Chan AK
Br J Haematol; 2005 Jun; 129(6):803-10. PubMed ID: 15953008
[TBL] [Abstract][Full Text] [Related]
8. von Willebrand factor and thrombin activation in children with newly diagnosed acute lymphoblastic leukemia: an impact of peripheral blasts.
Athale U; Moghrabi A; Nayiager T; Delva YL; Thabane L; Chan AK
Pediatr Blood Cancer; 2010 Jul; 54(7):963-9. PubMed ID: 20405515
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of thrombotic children with malignancy.
Unal S; Varan A; Yalçin B; Büyükpamukçu M; Gürgey A
Ann Hematol; 2005 Jun; 84(6):395-9. PubMed ID: 15735962
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis in children with acute lymphoblastic leukemia: part I. Epidemiology of thrombosis in children with acute lymphoblastic leukemia.
Athale UH; Chan AK
Thromb Res; 2003; 111(3):125-31. PubMed ID: 14678808
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C.
Pelland-Marcotte MC; Kulkarni K; Athale UH; Pole JD; Brandão LR; Sung L
Am J Hematol; 2021 Jul; 96(7):796-804. PubMed ID: 33848369
[TBL] [Abstract][Full Text] [Related]
12. Thrombosis in children with acute lymphoblastic leukemia Part III. Pathogenesis of thrombosis in children with acute lymphoblastic leukemia: effects of host environment.
Athale UH; Chan AK
Thromb Res; 2003; 111(6):321-7. PubMed ID: 14698648
[TBL] [Abstract][Full Text] [Related]
13. The association of mediastinal mass in the formation of thrombi in pediatric patients with non-lymphoblastic lymphomas.
Gartrell J; Kaste SC; Sandlund JT; Flerlage J; Zhou Y; Cheng C; Estepp J; Metzger ML
Pediatr Blood Cancer; 2020 Feb; 67(2):e28057. PubMed ID: 31736198
[TBL] [Abstract][Full Text] [Related]
14. Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols).
Mauz-Körholz C; Junker R; Göbel U; Nowak-Göttl U
Thromb Haemost; 2000 Jun; 83(6):840-3. PubMed ID: 10896235
[TBL] [Abstract][Full Text] [Related]
15. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
16. Children with acute lymphoblastic leukaemia have high plasma levels of total homocysteine at time of diagnosis.
Ruud E; Holmstrøm H; Brosstad F; Wesenberg F
Scand J Clin Lab Invest; 2006; 66(1):67-78. PubMed ID: 16464788
[TBL] [Abstract][Full Text] [Related]
17. The risk factors for thrombosis in children with acute lymphoblastic leukemia.
Sivaslioglu S; Gursel T; Kocak U; Kaya Z
Clin Appl Thromb Hemost; 2014 Sep; 20(6):651-3. PubMed ID: 23364161
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract][Full Text] [Related]
19. Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.
Torun YA; Patiroglu T; Ozdemir MA; Ozkul Y; Ekici A; Karakukcu M
Clin Appl Thromb Hemost; 2012; 18(2):218-21. PubMed ID: 21873357
[TBL] [Abstract][Full Text] [Related]
20. A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.
Kumar P; Mulhern RK; Regine WF; Rivera GK; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):561-6. PubMed ID: 7852120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
